Home LiteratureArticle Details
PMID: 14707114 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression.

The Journal of experimental medicine ·Vol. 199 ·No. 1 ·2004-01-05 ·Pages 47-58

Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G

Abstract

Inflammation removes developing and mature lymphocytes from the bone marrow (BM) and induces the appearance of developing B cells in the spleen. BM granulocyte numbers increase after lymphocyte reductions to support a reactive granulocytosis. Here, we demonstrate that inflammation, acting primarily through tumor necrosis factor alpha (TNFalpha), mobilizes BM lymphocytes. Mobilization reflects a reduced CXCL12 message and protein in BM and changes to the BM environment that prevents homing by cells from naive donors. The effects of TNFalpha are potentiated by interleukin 1 beta (IL-1beta), which acts primarily to expand the BM granulocyte compartment. Our observations indicate that inflammation induces lymphocyte mobilization by suppressing CXCL12 retention signals in BM, which, in turn, increases the ability of IL-1beta to expand the BM granulocyte compartment. Consistent with this idea, lymphocyte mobilization and a modest expansion of BM granulocyte numbers follow injections of pertussis toxin. We propose that TNFalpha and IL-1beta transiently specialize the BM to support acute granulocytic responses and consequently promote extramedullary lymphopoiesis.

MeSH Terms
Adoptive Transfer Animals Antigens, CD/genetics B-Lymphocytes/immunology Bone Marrow Cells/immunology Chemokine CXCL12 Chemokines, CXC/genetics Colony-Forming Units Assay Female Gene Expression Regulation/immunology Inflammation/immunology Mice Mice, Inbred C57BL Mice, Knockout Receptors, Tumor Necrosis Factor/deficiency,genetics Receptors, Tumor Necrosis Factor, Type I Receptors, Tumor Necrosis Factor, Type II Stromal Cells/immunology
Chemicals
Antigens, CD Chemokine CXCL12 Chemokines, CXC Cxcl12 protein, mouse Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor, Type I Receptors, Tumor Necrosis Factor, Type II
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ueda Yoshihiro
Department of Immunology, Box 3010, Duke University Medical Center, Durham, NC 27710, USA.
Yang Kaiyong
Foster Sandra J
Kondo Motonari
Kelsoe Garnett
References (56)
56 references, click to expand
  1. Neutropenia in high-risk neonates.
    J Pediatr. 1984 Dec;105(6):982-6 PMID: 6502353
  2. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q.
    J Immunol. 2002 May 15;168(10):5222-32 PMID: 11994479
  3. Interleukin-1 inhibition of B lymphopoiesis is reversible.
    Blood. 1988 Dec;72(6):2053-5 PMID: 3264197
  4. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells.
    Exp Hematol. 1989 Jan;17(1):38-45 PMID: 2535697
  5. The biology of cachectin/TNF--a primary mediator of the host response.
    Annu Rev Immunol. 1989;7:625-55 PMID: 2540776
  6. Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats.
    J Leukoc Biol. 1989 Jun;45(6):546-57 PMID: 2786048
  7. The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus.
    Ann N Y Acad Sci. 1989;554:75-80 PMID: 2544123
  8. In vivo administration of recombinant granulocyte-macrophage colony-stimulating factor results in a reversible inhibition of primary B lymphopoiesis.
    J Immunol. 1991 Jun 15;146(12):4204-8 PMID: 2040797
  9. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
    J Immunol. 1991 Jul 1;147(1):22-8 PMID: 1711076
  10. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization.
    Nature. 1999 Aug 12;400(6745):682-7 PMID: 10458165
  11. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues.
    Immunity. 1999 Aug;11(2):201-12 PMID: 10485655
  12. Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis.
    Arthritis Rheum. 1999 Sep;42(9):1828-32 PMID: 10513796
  13. Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice.
    Blood. 1992 Mar 1;79(5):1121-9 PMID: 1536940
  14. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins.
    Science. 1993 Jul 30;261(5121):600-3 PMID: 8342023
  15. Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites.
    Blood. 1994 Jan 15;83(2):377-85 PMID: 8286738
  16. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis.
    J Exp Med. 1994 Jun 1;179(6):1789-97 PMID: 8195708
  17. Neonatal neutropenia in low birthweight premature infants.
    Am J Perinatol. 1995 Jan;12(1):34-8 PMID: 7710574
  18. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords.
    J Exp Med. 1995 Aug 1;182(2):581-6 PMID: 7629515
  19. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells.
    Immunity. 1995 Oct;3(4):475-84 PMID: 7584138
  20. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18.
    Blood. 1996 Jul 1;88(1):146-57 PMID: 8704169
  21. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
    Nature. 1996 Aug 15;382(6592):635-8 PMID: 8757135
  22. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells.
    Science. 1996 Dec 20;274(5295):2092-4 PMID: 8953042
  23. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells.
    Science. 1996 Dec 20;274(5295):2094-7 PMID: 8953043
  24. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.
    J Exp Med. 1997 Jan 6;185(1):111-20 PMID: 8996247
  25. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.
    J Exp Med. 1997 Feb 3;185(3):517-30 PMID: 9053452
  26. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
    J Exp Med. 1996 Sep 1;184(3):1101-9 PMID: 9064327
  27. Characterization of tumor necrosis factor-deficient mice.
    Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8093-8 PMID: 9223320
  28. V(D)J recombination in mature B cells: a mechanism for altering antibody responses.
    Science. 1997 Oct 10;278(5336):298-301 PMID: 9323210
  29. V(D)J recombinase activity in a subset of germinal center B lymphocytes.
    Science. 1997 Oct 10;278(5336):301-5 PMID: 9323211
  30. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
    Nat Immunol. 2002 Jul;3(7):687-94 PMID: 12068293
  31. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    J Immunol. 2003 Feb 1;170(3):1136-40 PMID: 12538668
  32. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.
    Blood. 1998 Jan 1;91(1):100-10 PMID: 9414273
  33. Impairment of T and B cell development by treatment with a type I interferon.
    J Exp Med. 1998 Jan 5;187(1):79-87 PMID: 9419213
  34. Mature dendritic cells respond to SDF-1, but not to several beta-chemokines.
    Immunobiology. 1998 Mar;198(5):490-500 PMID: 9561368
  35. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.
    Nature. 1998 Jun 11;393(6685):595-9 PMID: 9634238
  36. Role of TNFR1 and TNFR2 in TNF-induced platelet consumption in mice.
    J Immunol. 1998 Jun 15;160(12):6182-6 PMID: 9637537
  37. V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling.
    Nature. 1998 Jul 16;394(6690):292-5 PMID: 9685161
  38. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.
    Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9448-53 PMID: 9689100
  39. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells.
    J Exp Med. 1998 Aug 17;188(4):765-72 PMID: 9705958
  40. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity.
    Eur J Immunol. 1998 Nov;28(11):3738-48 PMID: 9842916
  41. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.
    Immunity. 1999 Apr;10(4):463-71 PMID: 10229189
  42. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK.
    J Immunol. 1999 May 15;162(10):5671-5 PMID: 10229797
  43. The molecular characterization of the fetal stem cell marker AA4.
    Immunity. 1999 Jun;10(6):691-700 PMID: 10403644
  44. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.
    J Exp Med. 1999 Jul 5;190(1):75-89 PMID: 10429672
  45. Humoral immune responses in Cr2-/- mice: enhanced affinity maturation but impaired antibody persistence.
    J Immunol. 2000 May 1;164(9):4522-32 PMID: 10779753
  46. The biology of chemokines and their receptors.
    Annu Rev Immunol. 2000;18:217-42 PMID: 10837058
  47. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production.
    J Exp Med. 2000 Jun 19;191(12):2113-20 PMID: 10859336
  48. Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs.
    J Immunol. 2000 Sep 1;165(5):2362-6 PMID: 10946258
  49. Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice.
    J Exp Med. 2000 Dec 18;192(12):1745-54 PMID: 11120771
  50. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes.
    Eur J Immunol. 2001 Mar;31(3):699-707 PMID: 11241273
  51. Circulating human B cells that express surrogate light chains and edited receptors.
    Nat Immunol. 2000 Sep;1(3):207-13 PMID: 10973277
  52. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines.
    J Immunol. 2001 Apr 15;166(8):5145-54 PMID: 11290797
  53. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing.
    J Immunol. 2001 May 1;166(9):5749-54 PMID: 11313418
  54. Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive G alpha i proteins.
    Ann N Y Acad Sci. 2001 Jun;938:117-27; discussion 127-8 PMID: 11458498
  55. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.
    J Biol Chem. 2001 Nov 23;276(47):43503-8 PMID: 11571304
  56. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
    J Immunol. 1988 Jul 15;141(2):531-8 PMID: 3260256
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2004-01-05
Pages
47-58
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC1887733
Subset
IM
Grants
NIAID NIH HHS · R01 AI024335 · United States
NIAID NIH HHS · R01 AI049326 · United States
NIAID NIH HHS · U19 AI056363 · United States
NIAID NIH HHS · AI 56363 · United States
NIAID NIH HHS · AI 49326 · United States
NIAID NIH HHS · AI 24335 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com